Detalles de la búsqueda
1.
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical Activity.
Am J Pathol
; 186(8): 2162-2170, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27317903
2.
Personalizing lung cancer prevention through a reverse migration strategy.
Top Curr Chem
; 329: 221-40, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-22752582
3.
Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.
Carcinogenesis
; 31(10): 1755-61, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20627871
4.
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer.
Carcinogenesis
; 31(12): 2118-23, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20819778
5.
Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells.
Mol Cancer Ther
; 8(3): 521-32, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19276160
6.
Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck.
Clin Cancer Res
; 12(18): 5596-602, 2006 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17000697
7.
Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma.
Clin Cancer Res
; 12(2): 653-61, 2006 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16428512
8.
Focus on head and neck cancer.
Cancer Cell
; 5(4): 311-6, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15093538
9.
Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma.
J Clin Oncol
; 23(15): 3495-501, 2005 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15908659
10.
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.
J Clin Oncol
; 23(11): 2544-55, 2005 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15753462
11.
Results of a phase II double-blinded randomized clinical trial of difluoromethylornithine for cervical intraepithelial neoplasia grades 2 to 3.
Clin Cancer Res
; 11(1): 390-6, 2005 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15671570
12.
9-cis-retinoic acid treatment increases serum concentrations of alpha-tocopherol in former smokers.
Clin Cancer Res
; 11(6): 2305-11, 2005 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15788681
13.
Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokers.
J Natl Cancer Inst
; 95(2): 165-8, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12529350
14.
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.
J Natl Cancer Inst
; 94(9): 681-90, 2002 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11983757
15.
Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancer.
J Natl Cancer Inst
; 95(3): 198-205, 2003 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-12569141
16.
The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells.
Cancer Res
; 62(8): 2430-6, 2002 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11956107
17.
A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.
Cancer Res
; 62(17): 4992-5, 2002 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12208751
18.
Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma.
Cancer Res
; 62(22): 6414-7, 2002 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12438226
19.
Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype.
Oncogene
; 22(30): 4627-35, 2003 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-12879006
20.
Initial clinical trial of oral TAC-101, a novel retinoic acid receptor-alpha selective retinoid, in patients with advanced cancer.
J Clin Oncol
; 20(16): 3522-32, 2002 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12177113